ImmunologyJournal for ImmunoTherapy of CancerPeer-reviewed
A novel and potent MICA/B antibody is therapeutically effective in KRAS LKB1 mutant lung cancer models
Ryan R Kowash, Manoj Kumar Sabnani, Laura T. Gray…·Esra A. Akbay
This paper develops a novel MICA/B-targeting antibody that enhances NK cell activity and shows therapeutic efficacy in KRAS LKB1 mutant lung cancer models.
8 citations